Nicholas Way
3 Articles0 Comments

Monitoring revolution: a refrigeration story goes global

On November 1, the CCP Technologies share price stood at 1.7c. After a sharp run-up mid-year (it closed at 3.8c on June 5) with the announcement that two new prominent shareholders, James Spenceley, the founder and former chief executive of…

Noxopharm prepares for clinical trials

The Australian drug development company Noxopharm, which listed on the Australian Securities Exchange last August, has taken an important step forward in the treatment of secondary brain cancers, a major cause of death for cancer patients. Noxopharm is working with…

Crowdfunding a blow for ‘investor democracy’

There are many ways to describe crowdfunding, but the one I like best is “investor democracy”. In whatever form a crowdfunding project takes, it presents an opportunity for people who like an idea but have limited capital to participate. On…